Insulet (Nasdaq:PODD) announced today that it launched its Omnipod 5 insulin pump and Omnipod Discover platform in Spain. With the launch, Spain becomes the 26th country in which Insulet sells Omnipod and the 20th reached by Omnipod 5, the company’s latest-generation patch-based automated insulin delivery system. Omnipod 5 became the world’s first available tubeless, wearable, […]
Drug-Device Combinations
West completes sale of on-body drug delivery device to AbbVie
West Pharmaceutical Services (NYSE:WST) announced that it completed the sale of its SmartDose on-body delivery system to AbbVie. Exton, Pennsylvania-based West sold and transferred its manufacturing and supply rights for the SmartDose 3.5mL on-body delivery system and associated facilities to AbbVie. The companies closed their transaction, as planned, on July 1, 2026. West will continue […]
Tandem Diabetes Care launches t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in new geographies
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched the t:slim X2 insulin pump with the Abbott FreeStyle Libre 3 Plus in five new countries. San Diego-based Tandem launched the pairing of its flagship automated insulin delivery system with Control-IQ+ technology with Abbott’s latest continuous glucose monitor (CGM) sensor in the U.S. in October 2025. […]
BD names new president of Pharmacy Automation biz
BD (NYSE:BDX) announced today that it appointed Matthew Sassone as worldwide president of its Pharmacy Automation business. Sassone now leads the global business within the BD Medication Management Solutions business unit. His appointment goes into effect immediately. In the role, Sassone’s responsibilities include driving global strategy, performance and growth for Pharmacy Automation as part of […]
Terrestrial Bio doses first patients in GLP-1 patch trial
Terrestrial Bio announced today that it dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic semaglutide. Boston-based Terrestrial (formerly Vaxess Technologies) is evaluating VX-201, a needle-free microarray patch (MAP) in the trial. The company designed its MAP technology features a soluble microarray with tips that gradually dissolve into […]
MiniMed adds Alcon CEO, Medtronic exec to board of directors
MiniMed (Nasdaq:MMED) announced today that it appointed David Endicott and Linnea Burman to its board of directors, effective today. The appointments of Endicott and Burman expand MiniMed’s board from nine members to 11 members. Endicott, currently the CEO of Alcon, also joins the board’s Compensation and Talent Committee with the appointment. Northridge, California-based MiniMed’s latest […]
Insulet adds new board director
Insulet (Nasdaq:PODD) announced today that it appointed Jonathan (“Jay”) Mazelsky to its board of directors, effective July 1. Mazelsky joins the Acton, Massachusetts-based automated insulin delivery technology developer‘s board as an independent director. “We are pleased to welcome Jay to Insulet’s board of directors,” said Insulet President and CEO Ashley McEvoy. “Jay has a strong […]
Anodyne picks up $12.6M to advance once-weekly GLP-1 patch
Anodyne Nanotech announced today that it closed a $12.6 million Series A financing to support its transdermal drug delivery technology. Velocity Partners VC led the round with co-leaders Evercurious VC, alongside major participation from Relativity Healthcare Partners. Boston-based Anodyne plans to use proceeds to support the advancement of ANN-101, its once-weekly GLP-1 patch for obesity. […]
Modular Medical launches Pivot tubeless insulin patch pump
Modular Medical (Nasdaq:MODD) announced today that it commercially launched its new Pivot tubeless insulin patch pump. The rollout marks the start of real-world patient use of the Pivot pump. It marks San Diego-based Modular Medical’s transition to a commercial-stage medical device company. Modular Medical designed Pivot to make insulin pump therapy simpler to learn and […]
Dexcom launches enhanced Stelo app
Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience. San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. The company At ADA 2026, Dexcom said it planned to offer select users the opportunity for early […]
